US 9062075
Tetrahydropyridine derivatives as FabI inhibitors
granted A61KA61K31/4375A61K31/5377
Quick answer
US patent 9062075 (Tetrahydropyridine derivatives as FabI inhibitors) held by Aurigene Discovery Technologies Limited expires Mon Jun 18 2035 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Aurigene Discovery Technologies Limited
- Grant date
- Tue Jun 23 2015 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jun 18 2035 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 19
- CPC classes
- A61K, A61K31/4375, A61K31/5377, A61K31/55, A61K31/551